ophthalmologytimes14h
Qlaris Bio announces positive data from 2 clinical trials investigating QLS-111 in patients with primary open angle glaucoma and ocular hypertension
QLS‑111 is a novel topical formulation using Qlaris Bio’s ATP-sensitive potassium channel modulator platform. QLS-111 lowers ...
Daily5d
Use of speculum not solely responsible for postoperative ptosis: Study
A recent study explored the potential relationship between the use of speculums during phacoemulsification surgery and the ...
Too Old to Operate14d
A Plastic Surgery Primer for Clinicians Counseling on Cosmetic Procedures After Weight Loss, Part 2
Part 2 of a series outlining surgical cosmetic procedures after weight loss to assist clinicians in counseling patients on ...
ophthalmologytimes26d
Ocugen doses first patient in phase 1 trial of OCU200 for treatment of diabetic macular edema
OCU200 is a recombinant fusion protein targeting integrin receptors with anti-inflammatory and anti-VEGF properties, potentially transforming DME treatment. The phase 1 trial is a multicenter, ...
The New England Journal of Medicine1mon
Visceral Ptosis; A Review
Read before the Chirurgical Society of Boston, Sept. 17, 1914. Fellow in Gynecology, Harvard Medical School; Third Assistant Visiting Surgeon for Diseases of Women, Boston City Hospital; Assistant ...